118 related articles for article (PubMed ID: 31989567)
1. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2005; 291():171-8. PubMed ID: 15502222
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
[TBL] [Abstract][Full Text] [Related]
4. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
5. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
6. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
[TBL] [Abstract][Full Text] [Related]
7. Molecular Analysis of Mutations in the Human HPRT Gene.
Keohavong P; Xi L; Grant SG
Methods Mol Biol; 2020; 2102():349-359. PubMed ID: 31989566
[TBL] [Abstract][Full Text] [Related]
8. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
9. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
10. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
11. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
12. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
Champagne DP; Shockett PE
Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
[TBL] [Abstract][Full Text] [Related]
13. Novel types of mutation identified at the hprt locus of human T-lymphocytes.
Hou SM
Mutat Res; 1994 Jul; 308(1):23-31. PubMed ID: 7516483
[TBL] [Abstract][Full Text] [Related]
14. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens.
Fuscoe JC; Setzer RW; Collard DD; Moore MM
Carcinogenesis; 1996 May; 17(5):1013-20. PubMed ID: 8640906
[TBL] [Abstract][Full Text] [Related]
15. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells.
Chen CL; Fuscoe JC; Liu Q; Relling MV
Blood; 1996 Sep; 88(6):2210-8. PubMed ID: 8822941
[TBL] [Abstract][Full Text] [Related]
16. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract][Full Text] [Related]
17. Multiplex PCR analysis of in vivo-arising deletion mutations in the hprt gene of human T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
Environ Mol Mutagen; 1994; 23(2):89-95. PubMed ID: 8143706
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of mutations in the human HPRT gene.
Keohavong P; Xi L; Grant SG
Methods Mol Biol; 2014; 1105():291-301. PubMed ID: 24623237
[TBL] [Abstract][Full Text] [Related]
19. Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations.
Williams M; Rainville IR; Nicklas JA
Environ Mol Mutagen; 2002; 39(1):22-32. PubMed ID: 11813293
[TBL] [Abstract][Full Text] [Related]
20. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]